Shanghai Henlius Biotech Inc. - Class H

(OTC: SGBCF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and innovative biologics for patients with a focus on oncology and autoimmune diseases. The company operates in Mainland China and Overseas. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Contact Information

Website: www.henlius.com
Main Phone: +86 2133395800
Address: No. 1801 Hongmei Road
Address 2: 9/F, Innov Tower, Zone A
City / Town: Shanghai
Country: CN
Postal Code: 200233

Issuer Information

Exchange: OTO
Employees: 1873

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A